The pharmaceuticals drugs market in France is prepared to decline from $35.5 billion in 2017 to $34.16 billion in 2021, representing a negative compound annual rate of growth of 1%, according during the forecast period.

Latest reports states that in spite of France’s strong public health insurance system and rising senior population, increasing pressure on pharmaceutical commercialism costs, patent expiration of branded medication and exchange fluctuations area are effected the growth.

The government is presently that specialize in the employment of generics as a cost-containment tool to reduce expenditure. Certainly, the generics market was essentially run by a good regulative system and a constant wave of patent expiries, acting as a barrier to pharmaceutical market growth.

France follows external reference valuation, that is coupled with alternative European countries appreciate Federal Republic of Germany, Spain, Italy, and the UK. Pricing cut by any of those countries governments can quickly translate into cost reductions in France, and continual price cuts have reduced the increase in tending payment.

France’s compensation policy is grounded in clinical effectiveness instead of the cost-versus-benefit approach that other countries such as the US and the UK employ. This implies that pharmaceutical firms take a better risk so as to visualize returns on innovative products, and new medication need to demonstrate a level of improvement over existing products, which might be seen as a deterrent to investment.

Healthcare firms are searching for chances among the French market should focus on the growing demand for innovative medication and biotechnology, which is able to alter new therapies to command a premium value and influence the worth of the market. French government to support pharmaceutical R&D by giving  tax credits and financial commissions can promote new prospects for small biotechnology firms, a growing variety of that are operative in France over the past decade.

Table of Contents

1 Table of Contents

1.1 List of Tables

1.2 List of Figures

2 Executive Summary

3 Introduction

3.1 GlobalData Report Guidance

4 Overview of Pharmaceutical and Medical Device Markets

4.1 Pharmaceutical Market

4.1.1 Market Overview

4.1.2 Pharmaceutical Exports and Imports

4.1.3 Supply Channels

4.1.4 Market Segments

4.1.5 Major Therapeutic Areas

4.1.6 Major Players

4.2 Medical Device Market

4.2.1 Market Overview

4.2.2 Overview of Top Five Segments

4.2.3 Major Players

4.3 Market Drivers and Barriers

4.3.1 Drivers

4.3.2 Barriers

5 Market Access

5.1 Overview of Healthcare system

5.1.1 Reimbursement Process

5.1.2 Overview of Insurance Providers

5.1.3 Patient Share in Healthcare Expenditure

5.1.4 Price Trends in the Healthcare Sector

5.1.5 Pricing Policies

5.2 Regulatory Landscape

5.2.1 Overview of Regulatory Agencies

5.2.2 Market Authorization Procedure for Pharmaceutical Products

5.2.3 New Medical Device Approval Process

5.2.4 Licensing Process for Pharmaceutical and Medical Device Manufacturing

5.2.5 Exports and Imports

5.2.6 Intellectual Property Rights

5.2.7 Clinical Trial Regulations

5.2.8 Pharmaceutical Advertising Regulations

5.2.9 Pharmacy Regulations

5.2.10 Labeling and Packaging Regulations

6 Country Analysis

6.1 Political Environment

6.1.1 Political Structure

6.1.2 Current Political Environment

6.1.3 Healthcare Policy Initiatives

6.2 Economic Landscape

6.3 Economic Indicators

6.3.1 Gross Domestic Product

6.3.2 Gross National Income

6.3.3 Inflation

6.3.4 Currency Exchange Rate

6.3.5 Foreign Direct Investment

6.3.6 Foreign Exchange Reserves

6.3.7 Trade Balance

6.3.8 Government Structural Balance

6.3.9 Government Net Debt

6.3.10 Major Industries

6.4 Demographics

6.4.1 Population

6.4.2 Education and Literacy

6.4.3 Employment

6.4.4 Disease Burden

6.5 Healthcare Infrastructure

6.5.1 Healthcare Facilities

6.5.2 Healthcare Parameters

6.5.3 Environmental Health

6.5.4 Healthcare Personnel

6.6 Healthcare Expenditure

6.6.1 Overview

6.6.2 Share of Public and Private Sectors

6.6.3 Major Components of Healthcare Expenditure

6.6.4 Spending in Pharmaceutical R&D

6.7 Trade Associations

6.7.1 France Biotech

6.7.2 French Medical Device Association

6.7.3 French Pharmaceutical Association

6.8 Trade Fairs

7 Opportunities and Challenges

7.1 Opportunities

7.2 Challenges

8 Appendix

8.1 Abbreviations

8.2 Bibliography

8.3 Research Methodology

8.3.1 Coverage

8.3.2 Secondary Research

8.3.3 Forecasts

8.3.4 Expert Panel

8.4 Contact Us

8.5 Disclaimer

Key benefits of buying this profile include:

  • Develop business strategies by understanding the trends shaping and driving French healthcare market
  • Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact France’s healthcare market in the future
  • Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
  • Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment and strategic partnership

About GlobalData 

GlobalData is a leading provider of global business intelligence including market, competitor, and product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe, and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team.

About is a syndicated report platform with a wide variety of industry reports from reputed industry publishers. is promoted by DART Consulting. lists the variety of reports at the best price with seasonal discounts and promotion codes.

This report is available at

Contact us:

Direct: + 91-80- 4224 7136, 953-807- 6063


Share :